This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.80% per year. These returns cover a period from January 1, 1988 through August 3, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Are Medical Stocks Lagging Alpha Cognition Inc. (ACOG) This Year?
by Zacks Equity Research
Here is how Alpha Cognition Inc. (ACOG) and Actinium Pharmaceuticals (ATNM) have performed compared to their sector so far this year.
Is Alpha Cognition Inc. (ACOG) Stock Outpacing Its Medical Peers This Year?
by Zacks Equity Research
Here is how Alpha Cognition Inc. (ACOG) and Actinium Pharmaceuticals (ATNM) have performed compared to their sector so far this year.
Alpha Cognition Inc. (ACOG) Reports Q3 Loss, Tops Revenue Estimates
by Zacks Equity Research
Alpha Cognition Inc. (ACOG) delivered earnings and revenue surprises of +30.23% and +39.61%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
MDT Q2 Earnings Preview: Cardiovascular Unit Likely to Boost Growth
by Zacks Equity Research
Medtronic's Q2 results may see a lift from solid Cardiovascular momentum and strong Diabetes segment growth.
Alpha Cognition Inc. (ACOG) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Alpha Cognition Inc. (ACOG) delivered earnings and revenue surprises of -41.30% and +0.18%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
What Makes Alpha Cognition Inc. (ACOG) a New Strong Buy Stock
by Zacks Equity Research
Alpha Cognition Inc. (ACOG) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Is Alpha Cognition Inc. (ACOG) Outperforming Other Medical Stocks This Year?
by Zacks Equity Research
Here is how Alpha Cognition Inc. (ACOG) and Astellas Pharma Inc. (ALPMY) have performed compared to their sector so far this year.
Should You Buy Alpha Cognition Inc. (ACOG) After Golden Cross?
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
Alpha Cognition Inc. (ACOG) Reports Q1 Loss, Misses Revenue Estimates
by Zacks Equity Research
Alpha Cognition Inc. (ACOG) delivered earnings and revenue surprises of 65.52% and 26.78%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?